Evaluating the neuroprotective impact of senolytic drugs on human vision
Abstract Glaucoma, a chronic neurodegenerative disease of retinal ganglion cells (RGCs), is a leading cause of irreversible blindness worldwide. Its management currently focuses on lowering intraocular pressure to slow disease progression. However, disease-modifying, neuroprotective treatments for g...
Enregistré dans:
Auteurs principaux: | , , , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c1aad6bcbf894135b674b4437693f52f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|